tiprankstipranks
PMV Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer
The Fly

PMV Pharmaceuticals upgraded to Outperform from Perform at Oppenheimer

Oppenheimer upgraded PMV Pharmaceuticals (PMVP) to Outperform from Perform with a $6 price target

Don't Miss Our Christmas Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App